1.
Dimopoulos MA, Kastritis E, Delimpassi S, Zomas A, Kyrtsonis MC, Zervas K. The International Prognostic Scoring System for Waldenström’s macroglobulinemia is applicable in patients treated with rituximab-based regimens. Haematologica 2008; 93(9):1420-1422; https://doi.org/10.3324/haematol.12846.